Key result
Perioperative reviews highlight functional capacity, selective beta-blockers, statins, and updated antithrombotic guidelines.
This review provides an update on perioperative cardiac medicine, including risk assessment, medical therapy, and management of antiplatelet and anticoagulation therapies.
Updates perioperative cardiac risk strategies with beta-blockers, statins, and ARBs; leaves optimal stent and bridging protocols unresolved.
Recent studies have shed light on preoperative risk assessment, medical therapy to reduce postoperative cardiac complications (beta-blockers, statins, and angiotensin II receptor blockers [ARBs]), perioperative management of patients with coronary stents on antiplatelet therapy, and perioperative bridging anticoagulation.
No takes yet. Share an insight, caveat, or question.
Cohn et al. (2016) conducted a review in Cardiac risk in noncardiac surgery. Perioperative cardiac management was evaluated. Recent studies highlight the importance of functional capacity in risk assessment, selective use of beta-blockers for high-risk patients, perioperative statin protection, and updated guidelines for antiplatelet and bridging anticoagulation therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: